FDA Inspection 1053175 — Prescription Dispensing Laboratories Inc.
The FDA completed an inspection of Prescription Dispensing Laboratories Inc. on May 11, 2018 in Cedar Park, TX. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- May 11, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cedar Park, TX (United States)